Teladoc Health Surges 6.25% on $220M Volume Spike 227% Higher Ranking 495th in Market Activity

Teladoc Health (TDOC) surged 6.25% on October 3, 2025, with a trading volume of $220 million—227.43% higher than the previous day—ranking it 495th in market activity. The healthcare provider’s stock performance reflects renewed investor interest in digital health solutions amid evolving market dynamics.

Recent developments highlight Teladoc’s strategic focus on expanding its telehealth platform through partnerships with major insurers and healthcare systems. Analysts noted that the company’s integration of AI-driven diagnostic tools has positioned it to capture a larger share of the post-pandemic virtual care market. Additionally, regulatory tailwinds in mental health services and chronic disease management have bolstered optimism among stakeholders.

Key operational metrics released in the past week indicate a stabilization in user acquisition costs and a 12% year-over-year increase in enterprise client contracts. While the company remains cautious about macroeconomic headwinds, its Q3 earnings guidance aligns with expectations of sustained revenue growth in high-margin subscription services.

To run this back-test rigorously I need to clarify a couple of practical details and confirm assumptions that will affect how we construct the signals: 1. Universe definition • Which market(s) should the “top-500” stocks be drawn from? (e.g., all U.S. listed equities, only NYSE + NASDAQ, a specific country/region, etc.) • Should we filter out illiquid/penny stocks (e.g., price < $1) or ADRs, or include everything? 2. Ranking metric & timing • “Daily trading volume” – do you want to rank on the same day’s volume and buy at that day’s close, then exit at the next day’s close (T+1 hold)? • Alternatively, buy next day’s open to avoid look-ahead bias? (Both are common; please indicate your preference.) 3. Execution assumptions • Equal-weight each selected stock? • Commissions/slippage to include, or assume frictionless execution? 4. Output style • Do you want the strategy results presented on a portfolio (aggregate) level only, or also per-stock statistics? • Any benchmark to compare against (e.g., SPY, equal-weighted all-stock universe)? Our back-testing toolkit can handle a large daily-rebalanced portfolio but needs the above choices nailed down before we generate and run the signals. Let me know your preferences and I’ll proceed straight to data retrieval and back-testing.